当前位置:首页 - 行情中心 - 大洋生物(003017) - 财务分析 - 现金流量表

大洋生物

(003017)

  

流通市值:24.73亿  总市值:29.98亿
流通股本:6928.80万   总股本:8400.00万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金411,750,321.67213,380,946.05852,699,943.77626,563,417.37
  收到的税费返还15,111,664.923,632,465.5912,396,404.729,325,920.33
  收到其他与经营活动有关的现金20,281,445.0211,503,365.6224,233,561.4717,408,258.52
  经营活动现金流入小计447,143,431.61228,516,777.26889,329,909.96653,297,596.22
  购买商品、接受劳务支付的现金229,069,598.05125,653,067.76625,139,166.96453,594,417.23
  支付给职工以及为职工支付的现金61,707,141.9135,281,839.06119,136,230.6289,096,068.68
  支付的各项税费25,744,044.9714,268,38736,869,375.2528,548,058.75
  支付其他与经营活动有关的现金17,254,670.9310,702,513.0441,991,178.4728,511,210.79
  经营活动现金流出小计333,775,455.86185,905,806.86823,135,951.3599,749,755.45
  经营活动产生的现金流量净额113,367,975.7542,610,970.466,193,958.6653,547,840.77
二、投资活动产生的现金流量:
  收回投资收到的现金71,000,00068,000,00089,000,00040,000,000
  取得投资收益收到的现金581,027.61539,082.221,204,681.5973,986.15
  处置固定资产、无形资产和其他长期资产收回的现金净额--941,902.221,775,248
  投资活动现金流入小计71,581,027.6168,539,082.2291,146,583.7242,749,234.15
  购建固定资产、无形资产和其他长期资产支付的现金27,156,127.0216,070,825.2463,449,820.4745,594,752.45
  投资支付的现金48,000,00048,000,000195,000,000153,000,000
  投资活动现金流出小计75,156,127.0264,070,825.24258,449,820.47198,594,752.45
  投资活动产生的现金流量净额-3,575,099.414,468,256.98-167,303,236.75-155,845,518.3
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,940,0001,940,0001,000,000-
  其中:子公司吸收少数股东投资收到的现金1,940,0001,940,0001,000,000-
  取得借款收到的现金383,000,00070,000,000715,857,344.94544,970,255.56
  收到其他与筹资活动有关的现金12,266,823.8-35,849,216.4733,408,455.98
  筹资活动现金流入小计397,206,823.871,940,000752,706,561.41578,378,711.54
  偿还债务支付的现金448,437,232.75115,470,872.21598,499,641.3455,527,956.62
  分配股利、利润或偿付利息支付的现金27,466,684.591,052,267.3642,707,190.245,126,325.94
  支付其他与筹资活动有关的现金4,440,642.43,981,37144,935,673.8248,449,398.48
  筹资活动现金流出小计480,344,559.74120,504,510.57686,142,505.32549,103,681.04
  筹资活动产生的现金流量净额-83,137,735.94-48,564,510.5766,564,056.0929,275,030.5
四、汇率变动对现金及现金等价物的影响577,899.16430,911.33265,205478,442.88
五、现金及现金等价物净增加额27,233,039.56-1,054,371.86-34,280,017-72,544,204.15
  加:期初现金及现金等价物余额347,244,440.16347,244,440.16381,524,457.16381,524,457.16
  期末现金及现金等价物余额374,477,479.72346,190,068.3347,244,440.16308,980,253.01
补充资料:
  净利润50,295,967.72-63,735,511.21-
  资产减值准备13,679,742.76-8,957,738.67-
  固定资产和投资性房地产折旧30,764,320.36-64,976,473.25-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧30,764,320.36-64,976,473.25-
  无形资产摊销1,453,203.45-2,835,046.37-
  长期待摊费用摊销47,169.81-236,563.64-
  处置固定资产、无形资产和其他长期资产的损失---85,131.93-
  固定资产报废损失1,980,303.87-3,212,788.68-
  公允价值变动损失-296,228.9--1,472,424.84-
  财务费用2,408,848.38-6,502,006.56-
  投资损失1,121,628.15--728,520.93-
  递延所得税6,914,161.51-7,753,784.02-
  其中:递延所得税资产减少5,608,278.02-11,857,412.35-
    递延所得税负债增加1,305,883.49--4,103,628.33-
  存货的减少-1,482,081.81-30,200,175.62-
  经营性应收项目的减少-6,535,572.39--94,511,088.78-
  经营性应付项目的增加12,585,981.49--30,750,901.69-
  其他--4,460,511.44-
  现金的期末余额374,477,479.72-347,244,440.16-
  减:现金的期初余额347,244,440.16-381,524,457.16-
  现金及现金等价物的净增加额27,233,039.56--34,280,017-
公告日期2025-08-262025-04-222025-04-222024-10-19
审计意见(境内)标准无保留意见
TOP↑